Project AMAL Therapeutics – HLA Ligands presented by Dendritic Cells

Basic data

Acronym:
AMAL Therapeutics
Title:
HLA Ligands presented by Dendritic Cells
Duration:
01/01/2016 to 31/12/2016
Abstract / short description:
Von Dendritischen Zellen (DC) werden über HLA-Immunpräzipitation und Ligandenextraktion Peptid charakterisiert, die aus Selbstproteinen und Tumorantigenen stammen.

Involved staff

Managers

Immunology
Interfaculty Institute for Cell Biology (IFIZ), Interfaculty Institutes

Local organizational units

Immunology
Interfaculty Institute for Cell Biology (IFIZ)
Interfaculty Institutes

Funders

Genf, Switzerland
Help

will be deleted permanently. This cannot be undone.